|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | AGNP精神科治疗药物监测共识指南:2011显示文摘治疗药物监测(Therapeutic drug monitoring,TDM),如通过定量测定血清或血浆药物浓度指导用药剂量优化,已经成为对患者进行精神药物治疗的很有价值的工具。在患者用药依从性难以判断、药物耐受性不佳、治疗剂量下无效以及可能存在药代动力学药物-药物相互作用等情况下,测定药物浓度是很有用的。在精神科,有可能明显获益于TDM的主要患者群体包括儿童、孕妇、老年患者、智力障碍患者、涉及司法的患者、已知或怀疑携带药代动力学相关基因变异的患者,以及合并躯体疾病影响药代动力学的患者。然而,只有将TDM充分整合到临床治疗过程中去,才能发挥其优化药物治疗的潜在优势。为了促进TDM的合理应用,神经精神药理学与药物精神病学协会(Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie,AGNP)的TDM专家组在2004年发表了精神药物治疗药物监测指南。之后,随着知识不断更新,又有许多可能需要进行TDM的新药上市。因此,本次更新将神经精神药物的种类扩展到了128种,并将其TDM必要性划分为从'强烈推荐'到'可能有用'的四个等级。经过大量细致且全面的文献检索与分门别类的汇总整理,将基于循证医学理念的'治疗参考浓度范围'和'剂量相关参考浓度范围'呈现给大家。本共识指南引入了'实验室警戒浓度'的新概念,即实验室需要马上告知治疗医生的药物浓度上限。本共识指南还给出了诸如药物作为细胞色素P450酶的底物和抑制剂的性质,代谢物与母药浓度比值的常见范围,以及与结果解释相关的内容,还提供了何时将TDM与遗传药理学检测相结合的建议。遵循本指南,有助于改善许多患者精神药物治疗的效果,特别是那些存在药代动力学异常的患者。TDM是一门交叉学科,有时针对看起来不一致的数据,需要多学科坦诚地讨论,只有这样,患者才能从这种合作中获益。 | Hiemke C Baumann P Bergemann N Conca A Dietmaier O Egberts K Fric M Gerlach M Greiner C Gründer G Haen E Havemann-Reinecke U Jaquenoud Sirot E Kirchherr H Laux G Lutz UC Messer T Müller MJ Pfuhlmann B Rambeck B Riederer P Schoppek B Stingl J Uhr M Ulrich S Waschgler R Zernig G 李文标(译) 果伟(译) 阮灿军(译) 贺静(译) 汤宜朗(审校) 王传跃(审校) | 2016 | 实用药物与临床2016,19,10: | 37 |
| 2 | Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012显示文摘 | R. Phillip Dellinger Mitchell M. Levy Andrew Rhodes Djillali Annane Herwig Gerlach Steven M. Opal Jonathan E. Sevransky Charles L. Sprung Ivor S. Douglas Roman Jaeschke Tiffany M. Osborn Mark E. Nunnally Sean R. Townsend Konrad Reinhart Ruth M. Kleinpell | 2013 | Critical Care Medicine2013,,2: | 12 |
| 3 | Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012显示文摘 | R. P. Dellinger Mitchell M. Levy Andrew Rhodes Djillali Annane Herwig Gerlach Steven M. Opal Jonathan E. Sevransky Charles L. Sprung Ivor S. Douglas Roman Jaeschke Tiffany M. Osborn Mark E. Nunnally Sean R. Townsend Konrad Reinhart Ruth M. Kleinpell Derek | 2013 | Intensive Care Medicine2013,,2: | 7 |
| 4 | Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008显示文摘 | R. Phillip Dellinger Mitchell M. Levy Jean M. Carlet Julian Bion Margaret M. Parker Roman Jaeschke Konrad Reinhart Derek C. Angus Christian Brun-Buisson Richard Beale Thierry Calandra Jean-Francois Dhainaut Herwig Gerlach Maurene Harvey John J. Marini Joh | 2008 | Intensive Care Medicine2008,,1: | 7 |
| 5 | Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008显示文摘 | R Phillip Dellinger Mitchell M. Levy Jean M. Carlet Julian Bion Margaret M. Parker Roman Jaeschke Konrad Reinhart Derek C. Angus Christian Brun-Buisson Richard Beale Thierry Calandra Jean-Francois Dhainaut Herwig Gerlach Maurene Harvey John J. Marini John | 2008 | Critical Care Medicine2008,,1: | 4 |
| 6 | Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock显示文摘 | R. Phillip Dellinger Jean M. Carlet Henry Masur Herwig Gerlach Thierry Calandra Jonathan Cohen Juan Gea-Banacloche Didier Keh John C. Marshall Margaret M. Parker Graham Ramsay Janice L. Zimmerman Jean-Louis Vincent M. M. Levy | 2004 | Intensive Care Medicine2004,,4: | 3 |
| 7 | Transgastric pancreatography and EUS-guided drainage of the pancreatic duct显示文摘 | Uwe Will Frank Fueldner Anne-Kathrin Thieme Bernhard Goldmann Rainer Gerlach Igor Wanzar Frank Meyer | 2007 | Journal of Hepato - Biliary - Pancreatic Surgery2007,,4: | 2 |
| 8 | Molecular characterization of a protective outer membrane lipoprotein (OmlA)of from Actionbacillus pleuropneumoniae serotype 1 显示文摘 | Gerlach G F Anderson C Klashinsky S | 1993 | Infect Imumun1993,61,2: | 2 |
| 9 | Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock显示文摘 | R. Phillip Dellinger Jean M. Carlet Henry Masur Herwig Gerlach Thierry Calandra Jonathan Cohen Juan Gea-Banacloche Didier Keh John C. Marshall Margaret M. Parker Graham Ramsay Janice L. Zimmerman Jean-Louis Vincent Mitchell M. Levy | 2004 | Critical Care Medicine2004,,3: | 2 |
| 10 | The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis显示文摘 | Mitchell M. Levy R. Phillip Dellinger Sean R. Townsend Walter T. Linde-Zwirble John C. Marshall Julian Bion Christa Schorr Antonio Artigas Graham Ramsay Richard Beale Margaret M. Parker Herwig Gerlach Konrad Reinhart Eliezer Silva Maurene Harvey Susan Reg | 2010 | Intensive Care Medicine2010,,2: | 2 |
| 11 | 德国的阿片类依赖替代治疗(英文)显示文摘经过漫长而激烈的争论,德国于1987年首次引进了美沙酮维持治疗。最初,由于入治标准严格,接受治疗的人数很少,但自1990年后接受治疗的人数迅速上升,到2005年底已有61 000人。在德国每位全科医生只要完成了成瘾医学的培训都允许为阿片类成瘾病人开具替代治疗药物。目前德国有2700个全科医生在为阿片类药物成瘾病人开具处方。每位参加维持治疗的病人需接受社会心理治疗。研究结果和实践经验表明,病人从美沙酮维持治疗中获得了实质性的好处,他们的身心健康得到了改善。美沙酮维持治疗的留治率高(65% -85%),对HIV和肝炎的评估和坚持治疗十分重要;在促进病人回归社会方面也是极其重要的因素;在降低药物相关伤害方面如:减少共患疾病、死亡和预防感染性疾病具有重要的作用。有10%的人在长期的治疗过程中戒掉了毒品。虽然丁丙诺啡正在显示其重要性,但是美沙酮仍是主要的替代药物。在农村,参加美沙酮维持治疗仍是难题。虽然一致认为工作是治疗的正性因素,但对病人来说就业机会很少。德国监狱的替代治疗采用不同的准入和治疗模式。准入治疗不协调,参加治疗的人数很少。无论如何,在德国替代治疗在为药物使用者提供的卫生医疗系统中发挥了重要作用。 | Ingo Ilja MICHELS Heino STVER Ralf GERLACH | 2007 | 中国药物依赖性杂志2007,16,3: | 2 |
| 12 | The Surviving Sepsis Campaign: Results of an international guideline-based performance improvement program targeting severe sepsis显示文摘 | Mitchell M. Levy R Phillip Dellinger Sean R. Townsend Walter T. Linde-Zwirble John C. Marshall Julian Bion Christa Schorr Antonio Artigas Graham Ramsay Richard Beale Margaret M. Parker Herwig Gerlach Konrad Reinhart Eliezer Silva Maurene Harvey Susan Rega | 2010 | Critical Care Medicine2010,,2: | 2 |
| 13 | Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012显示文摘 | R. P. Dellinger Mitchell M. Levy Andrew Rhodes Djillali Annane Herwig Gerlach Steven M. Opal Jonathan E. Sevransky Charles L. Sprung Ivor S. Douglas Roman Jaeschke Tiffany M. Osborn Mark E. Nunnally Sean R. Townsend Konrad Reinhart Ruth M. Kleinpell Derek | 2013 | Intensive Care Medicine2013,,2: | 2 |
| 14 | The behaviour and ecology of the zebrafish, Danio rerio 显示文摘 | Spence R Gerlach G Lawrence C | 2008 | Biol Rev Camb Philos Soc2008,83,: | 1 |
| 15 | Open Reduction and Internal Fixation Versus Closed Treatment and Maadibuiomaxillary Fixation of Fractures of the Mandibular Condylar Process:A Randomized,Prospective,Multicenter Study With Special Evaluation of Fracture Level显示文摘 | Schneider M Erasmus F Gerlach KL | 2008 | Oral Maxillofacl Surg2008,66,12: | 1 |
| 16 | Long term liver cell cultures in bioreactors and possibl e application for liver support显示文摘 | | 1997 | Cell Biol Toxicol1997,13,45: | 1 |
| 17 | , Multipotential nestinpositive stem cells isolated from adult pancreatic islets differentiate in vivo into pancreatic endocrine, exocrine, and hepatic phenotypes 显示文摘 | Zulewski H Abraham E J Gerlach M J | 2001 | Diabetes2001,50,3: | 1 |
| 18 | Multipotential nestinpositive stem cells isolated from adult pancreatic islets differentiate in vivo into pancreatic endocrine, exocrine, and hepatic phenotypes显示文摘 | Zulewski H Abraham EJ Gerlach MJ | 2001 | Diabetes2001,50,3: | 1 |
| 19 | Overexpression of a transporter gene in a multidrug- resistnce human lung cancer cell line显示文摘 | Cloe SP Bhardwaj G Gerlach JH | 1992 | Science1992,258,: | 1 |
| 20 | CHAMP Gravity Field Recovery with the Energy Balance Approach显示文摘 | Gerlach C Sneeuw N Visser P | 2003 | Adv Geosciences2003,,1: | 1 |